All type of patients: 9 trials - Martin bevacizumab - AVADO (Miles) 7.5mg - AVADO (Miles) 15mg - RIBBON-2 (Brufsky) - RIBBON-I (Robert) on top capecitabine - RIBBON-I (Robert) on top Tax or anthra - E2100 (Miller) - AVF2119g (Miller) cape - Burstein
First line therapy: 6 trials - Martin bevacizumab - AVADO (Miles) 7.5mg - AVADO (Miles) 15mg - RIBBON-I (Robert) on top capecitabine - RIBBON-I (Robert) on top Tax or anthra - E2100 (Miller)
Second line therapy: 2 trials - RIBBON-2 (Brufsky) - AVF2119g (Miller) cape
6 trials - Herbst - Reck - Nishio - Herbst - Sandler - Johnson
3 trials - CALGB 90206 - AVOREN - Yang